Newsletter - January 2021
What’s Happening and What’s Next in Pharma
Via DHC →
Mark Bard (DHC Group), Wendy Blackburn (Intouch Group), and Dan Seewald (Deliberate Innovation), came together to discuss what’s ahead in 2021 for pharma organizations, brands, and individuals. The basis of this conversation is the new DHC Group and Intouch Group whitepaper, The Now and the Next. This in-depth conversation will be made available in two parts.
Read Part One of Interview →
Listening to Physicians
Via DHC/Sermo →
New data highlights from the most recent DHC and Sermo Physician Survey give us a sense of a baseline on physicians as we kick off 2021. Understanding physicians attitudes and behaviors is crucial to adapt to an ever-changing healthcare landscape. This infographic summarizes key highlights to help pharma marketers with HCP engagement decisions.
Read Now →
DHC Partner Insights
Client Trends: What’s Now and Next for Pharma DTC Marketing
Via WEGO Health →
As the Chief Client Officer of WEGO Health, Kristen Hartman has been at the forefront of DTC pharmaceutical marketing for over a decade. With the unique perspective of partnering with hundreds of pharma brands across varying therapeutic areas and pipeline stages, Kristen possesses the unique perspective of seeing it all. We caught up with Kristen to share the trends of today and the forecast of the future.
Read More →
CES Recap Video Series
Via CMI →
CES is not just a conference – as one of the biggest and most influential tech events of the year, it gives us a window into the top trends for the next 12 months and beyond. CMI created two videos showcasing the top trends and top products, curated by the Growth & Innovation team, that will make you feel like you were there.
View Part 1: The Top 5 Products Launches →
View Part 2: Top 3 Trends to Watch →
Point-of-Care Marketing: A Brand-Safe Investment in Tumultuous Times
Via PatientPoint →
Today’s tumultuous times continue to present even tougher challenges for healthcare marketers. While we can’t change the world around us (if only that was possible), there is reassurance of a safe space. The doctor’s office remains the most trusted, respected and relevant place for healthcare brands to connect with patients and healthcare providers.
Read More →
Unpacking the Future of Telemedicine: A CES Panel Follow Up
Via Healthline Media →
As the face of healthcare continues to evolve with the world around us, it is imperative that brands and marketers pay attention to potential pitfalls in the future of telehealth as we look ahead, beyond just the benefits. Check out three lessons for health marketers as it relates to telemedicine's role in our toolkit to engage with patients and providers.
Read More →
March Virtual Summit Series
DATE: March 3rd - 4th 2021
TIME: 12PM - 1:30PM EST
Join fellow colleagues and pharmaceutical marketers, researchers, and thought leaders for a virtual innovation Summit hosted by the Digital Health Coalition (DHC) and Merck. Over the course of two days, you will hear from both Merck leaders and industry colleagues via presenters and panelists in an interactive virtual format.
Sign Up Now →
DHC Partner News
The Now & The Next in Pharma Marketing
Our newest whitepaper, The Now & The Next in Pharma Marketing, explores practical solutions for the challenges that pharmaceutical organizations continue to face in light of the ongoing COVID-19 pandemic. This report leverages new research insights, practical solutions and proven tactics to implement now and help you evolve your commercial strategy.
Access Whitepaper →
Spotlight on Recent HCP Research
In this interview Matthew Holland (Chief Commercial Officer) and Adrienne Stevens, EdD (Head of Scientific Strategy) with Healio Strategic Solutions discuss how they are impacting healthcare provider (HCP) marketing innovation and share insights from three recent physician surveys.
Read the Interview & Data Summary →
Subscribe to Newsletter